Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,230) with videos related to
Page
of 123
Sort By:
Genome Biology
|
March 2, 2006
Comparison of dot chromosome sequences from D. melanogaster and D. virilis reveals an enrichment of DNA transposon sequences in heterochromatic domains
Elizabeth E Slawson, Christopher D Shaffer, Colin D Malone, et al.
Genome Research
|
January 6, 2011
Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes
Zhishuo Ou, Paweł Stankiewicz, Zhilian Xia, et al.
Data in Brief
|
January 6, 2022
Safety and biocompatibility of a bionic eye: Imaging, intraocular pressure, and histology data
Samuel C Eggenberger, Natalie L James, Cherry Ho, et al.
Analytical Chemistry
|
June 16, 2026
To the homeRNAmax: Developing an Improved Blood Self-Collection and Stabilization Platform for Remote Transcriptomic Studies
Madeleine Eakman, Filip Stefanovic, Jean Berthier, et al.
Biomaterials
|
November 12, 2021
Implantation and long-term assessment of the stability and biocompatibility of a novel 98 channel suprachoroidal visual prosthesis in sheep
Samuel C Eggenberger, Natalie L James, Cherry Ho, et al.
The Lancet. Oncology
|
April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.
Journal of Medicinal Chemistry
|
June 20, 1997
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors
A O Stewart, P A Bhatia, J G Martin, et al.
Breast Cancer Research and Treatment
|
December 18, 2012
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
Cynthia X Ma, Matthew J C Ellis, Gina R Petroni, et al.
JCO Precision Oncology
|
February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations
David M Hyman, Ben Tran, Luis Paz-Ares, et al.
Cell
|
September 4, 2012
A census of human soluble protein complexes
Pierre C Havugimana, G Traver Hart, Tamás Nepusz, et al.
Page
of 123
Search research articles
Search
Showing results (1201-1210 of 1,230) with videos related to
Sort By:
Page
of 123
Genome Biology
|
March 2, 2006
Comparison of dot chromosome sequences from D. melanogaster and D. virilis reveals an enrichment of DNA transposon sequences in heterochromatic domains
Elizabeth E Slawson, Christopher D Shaffer, Colin D Malone, et al.
Genome Research
|
January 6, 2011
Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes
Zhishuo Ou, Paweł Stankiewicz, Zhilian Xia, et al.
Data in Brief
|
January 6, 2022
Safety and biocompatibility of a bionic eye: Imaging, intraocular pressure, and histology data
Samuel C Eggenberger, Natalie L James, Cherry Ho, et al.
Analytical Chemistry
|
June 16, 2026
To the homeRNAmax: Developing an Improved Blood Self-Collection and Stabilization Platform for Remote Transcriptomic Studies
Madeleine Eakman, Filip Stefanovic, Jean Berthier, et al.
Biomaterials
|
November 12, 2021
Implantation and long-term assessment of the stability and biocompatibility of a novel 98 channel suprachoroidal visual prosthesis in sheep
Samuel C Eggenberger, Natalie L James, Cherry Ho, et al.
The Lancet. Oncology
|
April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.
Journal of Medicinal Chemistry
|
June 20, 1997
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors
A O Stewart, P A Bhatia, J G Martin, et al.
Breast Cancer Research and Treatment
|
December 18, 2012
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
Cynthia X Ma, Matthew J C Ellis, Gina R Petroni, et al.
JCO Precision Oncology
|
February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations
David M Hyman, Ben Tran, Luis Paz-Ares, et al.
Cell
|
September 4, 2012
A census of human soluble protein complexes
Pierre C Havugimana, G Traver Hart, Tamás Nepusz, et al.
Page
of 123